Two-protein signature of novel serological markers apolipoprotein-A2 and serum amyloid alpha predicts prognosis in patients with metastatic renal cell cancer and improves the currently used prognostic survival models (Q33519831)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Two-protein signature of novel serological markers apolipoprotein-A2 and serum amyloid alpha predicts prognosis in patients with metastatic renal cell cancer and improves the currently used prognostic survival models |
scientific article |
Statements
1 reference
Two-protein signature of novel serological markers apolipoprotein-A2 and serum amyloid alpha predicts prognosis in patients with metastatic renal cell cancer and improves the currently used prognostic survival models (English)
1 reference
J H Beijnen
1 reference
J S Vermaat
1 reference
I van der Tweel
1 reference
N Mehra
1 reference
S Sleijfer
1 reference
J B Haanen
1 reference
J M Roodhart
1 reference
J Y Engwegen
1 reference
C M Korse
1 reference
M H Langenberg
1 reference
W Kruit
1 reference
G Groenewegen
1 reference
R H Giles
1 reference
J H Schellens
1 reference
E E Voest
1 reference
18 December 2009
1 reference
1 reference
Identifiers
1 reference